LWM
TMO icon

Laidlaw Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Laidlaw Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,371
Closed -$1.26M – 239
2023
Q4 		$1.26M Sell
2,371
-15
-0.6% -$7.26K 0.46% 65
2023
Q3 		$1.21M Sell
2,386
-2,612
-52% -$1.39M 0.4% 76
2023
Q2 		$2.61M Sell
4,998
-22
-0.4% -$11.9K 0.51% 49
2023
Q1 		$2.89M Sell
5,020
-116
-2% -$65.4K 0.59% 43
2022
Q4 		$2.83M Sell
5,136
-609
-11% -$323K 0.61% 42
2022
Q3 		$2.91M Buy
5,745
+477
+9% +$267K 0.68% 35
2022
Q2 		$2.86M Sell
5,268
-251
-5% -$138K 0.58% 41
2022
Q1 		$3.26M Sell
5,519
-582
-10% -$334K 0.54% 45
2021
Q4 		$4.07M Buy
6,101
+476
+8% +$297K 0.65% 34
2021
Q3 		$3.21M Buy
+5,625
New +$3.09M 0.82% 34
2021
Q1 		– Sell
-5,088
Closed -$2.37M – 349
2020
Q4 		$2.37M Buy
5,088
+3,049
+150% +$1.43M 0.5% 55
2020
Q3 		$900K Buy
2,039
+76
+4% +$31.4K 0.4% 74
2020
Q2 		$711K Buy
1,963
+60
+3% +$20.1K 0.37% 77
2020
Q1 		$540K Buy
1,903
+328
+21% +$103K 0.35% 84
2019
Q4 		$512K Buy
+1,575
New +$478K 0.32% 92

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Laidlaw Wealth Management's TMO Position: Q1 2024 in Review

Laidlaw Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 2,371 shares — an estimated $1.26M sold.

Laidlaw Wealth Management first reported a position in TMO in Q4 2019 and held it in 15 quarters. The position peaked at $4.07M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Laidlaw Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Laidlaw Wealth Management sold 2,371 Thermo Fisher Scientific shares in Q1 2024, an estimated $1.26M.
  • Laidlaw Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 15 quarters.
  • Laidlaw Wealth Management's Thermo Fisher Scientific position peaked at $4.07M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Laidlaw Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.